Skip to content

Augmentation Therapy With Serotonin 5-HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies.

Systematic review · Neuropsychopharmacol Rep · 2025. Source record refreshed; an explanation has not been reviewed.

Systematic reviewSource: PubMed · PMID 40421605

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Augmentation Therapy With Serotonin 5-HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies.

Yamada R, Wada A, Stickley A et al.
Neuropsychopharmacol Rep · 2025

PubMed ID
40421605
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.